Psychiatric diagnosis

Government of Canada announces $16.5 million to support harm reduction and people who use substances in British Columbia

Friday, April 9, 2021 - 5:59pm

We remain committed to a comprehensive, evidence-based, and compassionate approach in supporting varied interventions to help people who use substances.

Key Points: 
  • We remain committed to a comprehensive, evidence-based, and compassionate approach in supporting varied interventions to help people who use substances.
  • These projects will reach several key groups in British Columbia, including Indigenous peoples, youth, post-secondary students, individuals in the correctional system, and healthcare professionals.
  • "Every life lost to an overdose is an empty seat in a classroom, at work or at the dinner table.
  • These organizations are doing important work to provide those experiencing problematic substance use with the support they need, which is saving lives."

Heroic Dose Event Explores Promise of Psychedelic Medicine for Veterans, Military & Servicemen and Women

Thursday, April 8, 2021 - 1:00pm

Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Microdose Psychedelic Insights , along with Entheon Biomedical Corp. , Bexson Biomedical , HavnLife and The Conscious Fund , present the Heroic Dose .

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Microdose Psychedelic Insights , along with Entheon Biomedical Corp. , Bexson Biomedical , HavnLife and The Conscious Fund , present the Heroic Dose .
  • The Heroic Dose will commence on 22nd April at 8:45 am EST.
  • This one-day virtual conference explores the use of psychedelic therapies for military veterans and first responders in an effort to combat the alarming rates of PTSD, substance abuse and suicide in this valuable yet underserved demographic.
  • This conference will feature some of the finest Navy SEAL and national security professionals, veterans and other servicemen and women, along with knowledgeable experts in psychedelic therapy, researchers, clinicians, companies, advocates.

Anxiety and Depression Treatment Market Revenue To Reach $24,467.7 Million by 2030 says P&S Intelligence

Thursday, April 8, 2021 - 8:30am

As a result of such initiatives, the global anxiety and depression treatment market value is predicted to increase from $17,770.9 million in 2020 to $24,467.7 million by 2030, at a 3.3% CAGR between 2021 and 2030, according to the market research report published by P&S Intelligence.

Key Points: 
  • As a result of such initiatives, the global anxiety and depression treatment market value is predicted to increase from $17,770.9 million in 2020 to $24,467.7 million by 2030, at a 3.3% CAGR between 2021 and 2030, according to the market research report published by P&S Intelligence.
  • Another such organization aiding the anxiety and depression treatment market growth with its support to patients and educational courses is the National Alliance on Mental Illness (NAMI), which was founded in the U.S. in 1979.
  • Due to the COVID-19 pandemic, the anxiety and depression treatment market reported negative impact.
  • P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world.

Anxiety and Depression Treatment Market Revenue To Reach $24,467.7 Million by 2030 says P&S Intelligence

Thursday, April 8, 2021 - 8:30am

As a result of such initiatives, the global anxiety and depression treatment market value is predicted to increase from $17,770.9 million in 2020 to $24,467.7 million by 2030, at a 3.3% CAGR between 2021 and 2030, according to the market research report published by P&S Intelligence.

Key Points: 
  • As a result of such initiatives, the global anxiety and depression treatment market value is predicted to increase from $17,770.9 million in 2020 to $24,467.7 million by 2030, at a 3.3% CAGR between 2021 and 2030, according to the market research report published by P&S Intelligence.
  • Another such organization aiding the anxiety and depression treatment market growth with its support to patients and educational courses is the National Alliance on Mental Illness (NAMI), which was founded in the U.S. in 1979.
  • Due to the COVID-19 pandemic, the anxiety and depression treatment market reported negative impact.
  • P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world.

Parkinson's Disease is Reviewed on Viewpoint, with host Dennis Quaid

Thursday, April 8, 2021 - 8:00am

MIAMI, April 8, 2021 /PRNewswire-PRWeb/ -- Up for discussion on TV's Viewpoint with host Dennis Quaid is Parkinson's disease, and how it affects countless individuals' lives daily.

Key Points: 
  • MIAMI, April 8, 2021 /PRNewswire-PRWeb/ -- Up for discussion on TV's Viewpoint with host Dennis Quaid is Parkinson's disease, and how it affects countless individuals' lives daily.
  • Approximately 60,000 people in the United States are diagnosed with Parkinson's disease every year, and over 10 million people worldwide live with the disorder.
  • Parkinson's disease is a progressive nervous system disorder that leads to stiffness, shaking, difficulty with balance, coordination, and walking.
  • Development Division, Viewpoint with host Dennis Quaid, 561-244-7620, info@viewpointproject.com

Gemiini Promoting The Shift From Awareness To Acceptance

Wednesday, April 7, 2021 - 10:40pm

SPOKANE, Wash., April 7, 2021 /PRNewswire/ -- Gemiini is celebrating Acceptance Month, a movement among advocacy organizations to increase understanding, acceptance, and support for people with autism.

Key Points: 
  • SPOKANE, Wash., April 7, 2021 /PRNewswire/ -- Gemiini is celebrating Acceptance Month, a movement among advocacy organizations to increase understanding, acceptance, and support for people with autism.
  • The original 2008 United Nations mandate for a "World Autism Awareness Day" undergoing a cultural shift.
  • As part of the growing recognition of the gifts and capacities that autistic individuals bring to our society, Gemiini has joined the movement to designate April as "Autistic Acceptance Month."
  • "Gemiini is committed to promoting acceptance ofpeople with autism into our social fabric through personalized therapies that increase speech, language, reading, life skills, and social skills," said Bryan Davey, Chief Executive Officer for Gemiini.

A Letter from the Hanna Family

Wednesday, April 7, 2021 - 6:00pm

Today, we reach out to share some personal Hanna Family news.

Key Points: 
  • Today, we reach out to share some personal Hanna Family news.
  • Doctors have diagnosed our dad, Jack Hanna, with dementia, now believed to be Alzheimer's disease.
  • His condition has progressed much faster in the last few months than any of us could have anticipated.
  • We are grateful that the many hearts he's touched over the years are with him during this journey, which gives us strength.

The Dementia Discovery Fund Significantly Enhances its Neuroscience R&D Expertise to Support its Portfolio

Wednesday, April 7, 2021 - 12:26pm

Dr. Jonathan Behr, Partner at The Dementia Discovery Fund,said, "We are delighted to welcome Lynne and Jim to DDF.

Key Points: 
  • Dr. Jonathan Behr, Partner at The Dementia Discovery Fund,said, "We are delighted to welcome Lynne and Jim to DDF.
  • Both are world-recognized experts in dementia and neuroscience R&D and their considerable expertise reinforces the key differentiation and value proposition of the DDF as we continue to invest in innovative dementia therapeutics and platform companies.
  • I look forward to working with my colleagues to help manage and expedite drug development to combat this dreadful disease."
  • The Dementia Discovery Fund (DDF) is a 250m specialist venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic approaches for dementias including Alzheimer's disease.

The Dementia Discovery Fund Significantly Enhances its Neuroscience R&D Expertise to Support its Portfolio

Wednesday, April 7, 2021 - 12:24pm

Dr. Jonathan Behr, Partner at The Dementia Discovery Fund,said, "We are delighted to welcome Lynne and Jim to DDF.

Key Points: 
  • Dr. Jonathan Behr, Partner at The Dementia Discovery Fund,said, "We are delighted to welcome Lynne and Jim to DDF.
  • Both are world-recognized experts in dementia and neuroscience R&D and their considerable expertise reinforces the key differentiation and value proposition of the DDF as we continue to invest in innovative dementia therapeutics and platform companies.
  • I look forward to working with my colleagues to help manage and expedite drug development to combat this dreadful disease."
  • The Dementia Discovery Fund (DDF) is a 250m specialist venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic approaches for dementias including Alzheimer's disease.

Mednet Announces New Discount Program to Support Parkinson's Disease Awareness Month

Tuesday, April 6, 2021 - 6:40pm

MINNEAPOLIS, April 6, 2021 /PRNewswire/ --In recognition of Parkinson's Disease Awareness Month, Mednet, a healthcare technology company, announced a new program to support research organizations conducting Parkinson's Disease (PD) research or any type of central nervous system (CNS) studies.

Key Points: 
  • MINNEAPOLIS, April 6, 2021 /PRNewswire/ --In recognition of Parkinson's Disease Awareness Month, Mednet, a healthcare technology company, announced a new program to support research organizations conducting Parkinson's Disease (PD) research or any type of central nervous system (CNS) studies.
  • The new program is designed to make it easier and more cost effective for research organizations to conduct studies in this important therapeutic category.
  • Mednet will offer the discount program with research studies with contracts quoted between April 1, 2021 and June 30, 2021, with executed contracts before September 30, 2021.This discount cannot be combined with any other discounts already offered by Mednet.
  • To learn more about how to access this new Mednet discount program, contact us .